Is NYXH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NYXH. It does not provide personalized investment advice.

NYXH (Nyxoah SA Ordinary Shares) Stock Analysis - Financials

Nyxoah SA Ordinary Shares (NYXH) is a publicly traded Healthcare sector company. As of August 24, 2026, NYXH trades at $1.65 with a market cap of $160.12M and a P/E ratio of 0.00. NYXH moved +3.13% today. Year to date, NYXH is -65.22%; over the trailing twelve months it is -74.80%. Its 52-week range spans $1.26 to $11.87. Analyst consensus is buy with an average price target of $4.26. Rallies surfaces NYXH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are NYXH's key financials?

NYXH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NYXH recently traded at $1.65. Market cap is $160.12M. P/E ratio is 0.00. Revenue is $0.

NYXH Key Metrics

Key financial metrics for NYXH
Metric	Value
Price	$1.65
Market Cap	$160.12M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$11.87
52-Week Low	$1.26
Volume	10
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

NYXH Analyst Consensus

5 analysts cover NYXH: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.26.

Common questions about NYXH

What are NYXH's key financials?: NYXH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NYXH recently traded at $1.65. Market cap is $160.12M. P/E ratio is 0.00. Revenue is $0.
Is NYXH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NYXH. It does not provide personalized investment advice.